Purchase Order N3239826P0008
Award Date 3/5/26
Potential Completion Date 7/31/26
Potential Value $45K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Naval Medical Research Command, on behalf of the Bureau of Medicine and Surgery, issued a purchase order to Biofire Defense LLC on June 1, 2025, for biofire diagnostic assay test panels with a ceiling value of $195,034.32. The order procures supplies for Global Fever Special Pathogens Panel, Warrior Panel, and Respiratory Panel assay testing under firm fixed-price commercial item terms. Place of performance is Silver Spring, Maryland. The ultimate completion date is March 1, 2028. The...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a U.S. Navy organization, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of 100 "Global Fever Panel - RUO, 6 Tests" products, which are diagnostic assays used for infectious disease testing and biodefense applications. The contract has a ceiling value of $99,270.00 and a period of performance ending on February 1, 2019. This award was...
- This is a fixed-price purchase order contract awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the supply of CAT #1768, BUFFER 10X W/BSA, with a ceiling value of $78,100.00 and a completion date of July 22, 2018. The contract has no set-aside designation. Biofire Defense LLC is a prime contractor that has received previous federal contract and...
- The Bureau of Medicine and Surgery awarded a $18,034 firm fixed-price purchase order to Biofire Defense LLC on December 3, 2024, for the BIOFIRE DEFENSE PRODUCT NGDS-ASY-0017. The contract, which requires completion by February 28, 2025, will be performed in Frederick, Maryland. This purchase order represents a tactical procurement from Biofire Defense, a Salt Lake City-based manufacturer specializing in molecular diagnostic technologies and biological agent identification products. No set-aside...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price delivery order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The order is for a Gastrointestinal Panel IVD (In Vitro Diagnostic), consisting of 30 tests, with a potential value of $59,312.89 and a completion date of April 2, 2024. The contract is issued under the General Services Administration's Multiple Award Schedule (MAS) program...
- This firm fixed-price purchase order was awarded by the Bureau of Medicine and Surgery, a defense agency within the U.S. Department of the Navy, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $69,801.94 contract is for the delivery of FilmArray Respiratory Panels 2.1, a diagnostic assay used to detect respiratory pathogens. The award has a completion date of September 30, 2025 and does not utilize a set-aside...
- This is a $114,761.00 firm fixed-price purchase order awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a limited liability company and manufacturer of goods, for the delivery of a FILMARRAY RESP PANEL product under PRODUCT CODE 423742. The contract has a completion date of September 30, 2022 and was awarded on July 12, 2022. There is no set-aside designation noted. Biofire Defense is an experienced federal contractor, having previously provided...
- This is a $83,175 firm fixed price purchase order awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC on March 31, 2020 for the delivery of COVID-19 coronavirus test kits. The contract has a performance period ending on September 30, 2020. Biofire Defense is a for-profit limited liability company that manufactures biological agent identification products, including diagnostic testing systems, and has previously held prime and subcontract awards to provide...
- This is a $99,397.75 firm fixed-price delivery order awarded to Biofire Defense LLC by the Department of the Navy's Bureau of Medicine and Surgery. The contract is for the provision of 30-test Respiratory Panel 2 IVD test kits, with an ultimate completion date of October 14, 2020. The award is under the Multiple Award Schedule (MAS) contract vehicle and is related to the Coronavirus COVID-19 National Interest Action. Biofire Defense is a for-profit limited liability company that has received...
- This federal contract award, with ID N6264519P0076, was made by the Bureau of Medicine and Surgery (BUMED), a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The $78,492.00 firm fixed-price purchase order is for the delivery of "GLOBAL FEVER PANELS (INCREMENT #1)" and has an ultimate completion date of February 5, 2020. Biofire Defense is a manufacturer of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II...
The Department of the Navy's Bureau of Medicine and Surgery awarded a purchase order to Biofire Defense LLC on March 5, 2026, for in-vitro diagnostic substances, reagents, and test kits, with a ceiling value of $45,128.56. The order carries no set-aside designation and procures 3,000 units of Buffer 10X with BSA-50mM MgCL2 with orange cap under FAR Part 12 commercial item procedures. Performance is located in Frederick, Maryland. The order is due for completion by July 31, 2026, and originated from a Special Notice solicitation issued February 25, 2026, with a March 2, 2026 submission deadline, announcing the Navy's intent to award a sole source contract to Biofire Defense for brand name equipment.
Generated 6/4/26, 12:19 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
In-Vitro Diagnostic Substances, Reagents, Test Kits | N3239826Q4997 | Department of the Navy Naval Supply Systems Command | Special Notice 1/1 | 2/25/26, 10:07 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 3/4/26 |